Cargando…

Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients

BACKGROUND: Treacher Collins syndrome (TCS) is an autosomal dominant craniofacial disorder caused by frameshift deletions or duplications in the TCOF1 gene. These mutations cause premature termination codons, which are predicted to lead to mRNA degradation by nonsense mediated mRNA decay (NMD). Hapl...

Descripción completa

Detalles Bibliográficos
Autores principales: Masotti, Cibele, Ornelas, Camila C, Splendore-Gordonos, Alessandra, Moura, Ricardo, Félix, Têmis M, Alonso, Nivaldo, Camargo, Anamaria A, Passos-Bueno, Maria Rita
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801500/
https://www.ncbi.nlm.nih.gov/pubmed/20003452
http://dx.doi.org/10.1186/1471-2350-10-136
_version_ 1782175931452882944
author Masotti, Cibele
Ornelas, Camila C
Splendore-Gordonos, Alessandra
Moura, Ricardo
Félix, Têmis M
Alonso, Nivaldo
Camargo, Anamaria A
Passos-Bueno, Maria Rita
author_facet Masotti, Cibele
Ornelas, Camila C
Splendore-Gordonos, Alessandra
Moura, Ricardo
Félix, Têmis M
Alonso, Nivaldo
Camargo, Anamaria A
Passos-Bueno, Maria Rita
author_sort Masotti, Cibele
collection PubMed
description BACKGROUND: Treacher Collins syndrome (TCS) is an autosomal dominant craniofacial disorder caused by frameshift deletions or duplications in the TCOF1 gene. These mutations cause premature termination codons, which are predicted to lead to mRNA degradation by nonsense mediated mRNA decay (NMD). Haploinsufficiency of the gene product (treacle) during embryonic development is the proposed molecular mechanism underlying TCS. However, it is still unknown if TCOF1 expression levels are decreased in post-embryonic human cells. METHODS: We have estimated TCOF1 transcript levels through real time PCR in mRNA obtained from leucocytes and mesenchymal cells of TCS patients (n = 23) and controls (n = 18). Mutational screening and analysis of NMD were performed by direct sequencing of gDNA and cDNA, respectively. RESULTS: All the 23 patients had typical clinical features of the syndrome and pathogenic mutations were detected in 19 of them. We demonstrated that the expression level of TCOF1 is 18-31% lower in patients than in controls (p < 0.05), even if we exclude the patients in whom we did not detect the pathogenic mutation. We also observed that the mutant allele is usually less abundant than the wild type one in mesenchymal cells. CONCLUSIONS: This is the first study to report decreased expression levels of TCOF1 in TCS adult human cells, but it is still unknown if this finding is associated to any phenotype in adulthood. In addition, as we demonstrated that alleles harboring the pathogenic mutations have lower expression, we herein corroborate the current hypothesis of NMD of the mutant transcript as the explanation for diminished levels of TCOF1 expression. Further, considering that TCOF1 deficiency in adult cells could be associated to pathologic clinical findings, it will be important to verify if TCS patients have an impairment in adult stem cell properties, as this can reduce the efficiency of plastic surgery results during rehabilitation of these patients.
format Text
id pubmed-2801500
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28015002010-01-05 Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients Masotti, Cibele Ornelas, Camila C Splendore-Gordonos, Alessandra Moura, Ricardo Félix, Têmis M Alonso, Nivaldo Camargo, Anamaria A Passos-Bueno, Maria Rita BMC Med Genet Research article BACKGROUND: Treacher Collins syndrome (TCS) is an autosomal dominant craniofacial disorder caused by frameshift deletions or duplications in the TCOF1 gene. These mutations cause premature termination codons, which are predicted to lead to mRNA degradation by nonsense mediated mRNA decay (NMD). Haploinsufficiency of the gene product (treacle) during embryonic development is the proposed molecular mechanism underlying TCS. However, it is still unknown if TCOF1 expression levels are decreased in post-embryonic human cells. METHODS: We have estimated TCOF1 transcript levels through real time PCR in mRNA obtained from leucocytes and mesenchymal cells of TCS patients (n = 23) and controls (n = 18). Mutational screening and analysis of NMD were performed by direct sequencing of gDNA and cDNA, respectively. RESULTS: All the 23 patients had typical clinical features of the syndrome and pathogenic mutations were detected in 19 of them. We demonstrated that the expression level of TCOF1 is 18-31% lower in patients than in controls (p < 0.05), even if we exclude the patients in whom we did not detect the pathogenic mutation. We also observed that the mutant allele is usually less abundant than the wild type one in mesenchymal cells. CONCLUSIONS: This is the first study to report decreased expression levels of TCOF1 in TCS adult human cells, but it is still unknown if this finding is associated to any phenotype in adulthood. In addition, as we demonstrated that alleles harboring the pathogenic mutations have lower expression, we herein corroborate the current hypothesis of NMD of the mutant transcript as the explanation for diminished levels of TCOF1 expression. Further, considering that TCOF1 deficiency in adult cells could be associated to pathologic clinical findings, it will be important to verify if TCS patients have an impairment in adult stem cell properties, as this can reduce the efficiency of plastic surgery results during rehabilitation of these patients. BioMed Central 2009-12-14 /pmc/articles/PMC2801500/ /pubmed/20003452 http://dx.doi.org/10.1186/1471-2350-10-136 Text en Copyright ©2009 Masotti et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Masotti, Cibele
Ornelas, Camila C
Splendore-Gordonos, Alessandra
Moura, Ricardo
Félix, Têmis M
Alonso, Nivaldo
Camargo, Anamaria A
Passos-Bueno, Maria Rita
Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients
title Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients
title_full Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients
title_fullStr Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients
title_full_unstemmed Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients
title_short Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients
title_sort reduced transcription of tcof1 in adult cells of treacher collins syndrome patients
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801500/
https://www.ncbi.nlm.nih.gov/pubmed/20003452
http://dx.doi.org/10.1186/1471-2350-10-136
work_keys_str_mv AT masotticibele reducedtranscriptionoftcof1inadultcellsoftreachercollinssyndromepatients
AT ornelascamilac reducedtranscriptionoftcof1inadultcellsoftreachercollinssyndromepatients
AT splendoregordonosalessandra reducedtranscriptionoftcof1inadultcellsoftreachercollinssyndromepatients
AT mouraricardo reducedtranscriptionoftcof1inadultcellsoftreachercollinssyndromepatients
AT felixtemism reducedtranscriptionoftcof1inadultcellsoftreachercollinssyndromepatients
AT alonsonivaldo reducedtranscriptionoftcof1inadultcellsoftreachercollinssyndromepatients
AT camargoanamariaa reducedtranscriptionoftcof1inadultcellsoftreachercollinssyndromepatients
AT passosbuenomariarita reducedtranscriptionoftcof1inadultcellsoftreachercollinssyndromepatients